Apart from the traditional surgery and chemotherapy, several new drugs targeting vascular endothelial growth factor (VEGF) 2 and epidermal growth factor receptor (EGFR) 3 have been used in combination with chemotherapy to treat patients with advanced CRC. Here, EGFR is linked to colorectal carcinoma.